We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $1.95B
1-Year Est. Return 45.61%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
–
AUM
$262M
AUM Growth
-$47.5M
Cap. Flow
-$29.3M
Cap. Flow %
-11.2%
Top 10 Hldgs %
65.95%
Holding
44
New
1
Increased
12
Reduced
5
Closed
6

Top Buys

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$2.52M
2
RLAY icon
Relay Therapeutics
RLAY
+$2.36M
3
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$2.23M
4
ARVN icon
Arvinas
ARVN
+$1.98M
5
SLDB icon
Solid Biosciences
SLDB
+$1.62M

Top Sells

Rank Stock Value
1
ASTL icon
Algoma Steel
ASTL
+$20.4M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$9.88M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.96M
4
TVTX icon
Travere Therapeutics
TVTX
+$3.21M
5
APLS
Apellis Pharmaceuticals
APLS
+$2.95M

Sector Composition

Rank Sector Weight
1 Healthcare 99.25%
2 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVIIW
26
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$67.1K 0.03%
548,000
– –
AFTR.WS
27
DELISTED
AfterNext HealthTech Acquisition Corp Warrants
AFTR.WS
$61.1K 0.02%
366,666
– –
ZTAQW
28
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
$60.1K 0.02%
358,270
– –
HCNEW
29
DELISTED
Jaws Hurricane Acquisition Corp. Warrant
HCNEW
$60.1K 0.02%
387,249
– –
IVCPW
30
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$59.9K 0.02%
490,000
– –
CDAQW
31
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$59.8K 0.02%
459,906
– –
CCVI.WS
32
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$59.4K 0.02%
540,000
– –
CORS.WS
33
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$53.6K 0.02%
334,666
– –
SNRHW
34
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$51.3K 0.02%
1,014,000
– –
CNDA.WS
35
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$28.6K 0.01%
408,333
– –
CLDI.WS
36
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$26.9K 0.01%
655,200
– –
TWCBW
37
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
$23.9K 0.01%
183,749
– –
SKYAW
38
DELISTED
Skydeck Acquisition Corp. Warrants
SKYAW
$18.1K 0.01%
361,756
– –
ASTL icon
39
Algoma Steel
ASTL
$404M
– –
-3,219,441
Closed -$20.4M
IOVA icon
40
Iovance Biotherapeutics
IOVA
$2.23B
– –
-1,545,589
Closed -$9.88M
LVRAW
41
DELISTED
Levere Holdings Corp. Warrant
LVRAW
– –
-274,999
Closed -$4K
SMIHW
42
DELISTED
Summit Healthcare Acquisition Corp. Warrant
SMIHW
– –
-489,999
Closed -$139K
BACA.WS
43
DELISTED
Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50
BACA.WS
– –
-862,499
Closed -$31K
CPARW
44
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
– –
-336,666
Closed -$1K
1
2

Similar funds

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $1.94B AUM 25.76% 1-Year Est. Return
MWA
Midland Wealth Advisors Effingham, Illinois $1.94B AUM 14.31% 1-Year Est. Return

Finepoint Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Finepoint Capital held 44 positions worth $262M, down 15% from $309M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Finepoint Capital withdrew a net $29.3M in Q1 2023, closing 6 positions and reducing 5 holdings. Its most notable exit was Algoma Steel, an estimated $20.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 90% a quarter earlier, followed by Materials.

Against the trend, Finepoint Capital opened a new position in LakeShore Biopharma Warrants worth $76.3K.

  • Finepoint Capital's largest Q1 2023 buy was LakeShore Biopharma Warrants: 489,999 shares worth $76.3K.
  • Finepoint Capital added most to Ascendis Pharma A/S in Q1 2023, an estimated $2.52M increase.
  • Finepoint Capital's biggest Q1 2023 reduction was Acadia Pharmaceuticals, cutting an estimated $4.96M.
  • Finepoint Capital fully exited Algoma Steel in Q1 2023, selling an estimated $20.4M.
  • Finepoint Capital's ten largest holdings make up 66% of its $262M portfolio in Q1 2023.
  • Finepoint Capital opened 1 new position and closed 6 in Q1 2023.
  • Finepoint Capital's portfolio value fell 15% quarter-over-quarter to $262M.

Based on Finepoint Capital's 13F filing for Q1 2023, filed 12 May 2023.